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Abstract
Background: Homelessness and associated mortality and multimorbidity rates are increasing. Systematic reviews
have demonstrated a lack of complex interventions that decrease unscheduled emergency health services
utilisation or increase scheduled care. Better evidence is needed to inform policy responses. We examined the
feasibility of a complex intervention (PHOENIx: Pharmacist led Homeless Outreach Engagement Nonmedical
Independent prescribing (Rx)) to inform a subsequent pilot randomised controlled trial (RCT).
Methods: Non-randomised trial with Usual Care (UC) comparator group set in Greater Glasgow and Clyde Health
Board, Scotland. Participants were adult inpatients experiencing homelessness in a city centre Glasgow hospital,
referred to the PHOENIx team at the point of hospital discharge, from 19th March 2018 until 6th April 2019. The
follow up period for each patient started on the day the patient was first seen (Intervention group) or first referred
(UC), until 24th August 2019, the censor date for all patients. All patients were offered and agreed to receive serial
consultations with the PHOENIx team (NHS Pharmacist prescriber working with Simon Community Scotland (third
sector homeless charity worker)). Patients who could not be reached by the PHOENIx team were allocated to the
UC group. The PHOENIx intervention included assessment of physical/mental health, addictions, housing, benefits
and social activities followed by pharmacist prescribing with referral to other health service specialities as necessary.
All participants received primary (including specialist homelessness health service based general practitioner care,
mental health and addictions services) and secondary care. Main outcome measures were rates of: recruitment;
retention; uptake of the intervention; and completeness of collected data, from recruitment to censor date.
(Continued on next page)
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: Richard.lowrie@ggc.scot.nhs.uk
1Homeless Health, Pharmacy Services, Clarkston Court, NHS Greater Glasgow
& Clyde, 56 Busby Road, Clarkston, Glasgow G76 7AT, UK
Full list of author information is available at the end of the article
Lowrie et al. International Journal for Equity in Health           (2021) 20:19 
https://doi.org/10.1186/s12939-020-01337-7
(Continued from previous page)
Results: Twenty four patients were offered and agreed to participate; 12 were reached and received the
intervention as planned with a median 7.5 consultations (IQR3.0–14.2) per patient. The pharmacist prescribed a
median of 2 new (IQR0.3–3.8) and 2 repeat (1.3–7.0) prescriptions per patient; 10(83%) received support for benefits,
housing or advocacy. Twelve patients were not subsequently contactable after leaving hospital, despite agreeing to
participate, and were assigned to UC. Two patients in the UC group died of drug/alcohol overdose during follow
up; no patients in the Intervention group died. All 24 patients were retained in the intervention or UC group until
death or censor date and all patient records were accessible at follow up: 11(92%) visited ED in both groups, with
11(92%) hospitalisations in intervention group, 9(75%) UC. Eight (67%) intervention group patients and 3(25%) UC
patients attended scheduled out patient appointments.
Conclusions: Feasibility testing of the PHOENIx intervention suggests merit in a subsequent pilot RCT.
Keywords: Homelessness inequality policy service, Pharmacist, Prescribing
Introduction
Homelessness encompasses rough sleeping, living in un-
suitable or temporary accommodation e.g. shelters, or
sofa surfing [1]. The risks of experiencing homelessness
are based on a set of individual and structural factors
such as childhood poverty, experiencing abuse, a lack of
support or lack of affordable housing, most of which are
out with the control of the individual [2]. The prevalence
of homelessness has increased since 2016 when there
were 34,100 homeless applications: in 2018–19 homeless
applications increased to 36,465 (0.7% of the Scottish
population). Glasgow experienced the greatest increase
in Scotland, from 5274 in 2018 to 5873 (0.93% of the
Glasgow population) in 2019 [3]. In England, rates of
rough sleeping have doubled in the past 6 years, [4]
impacting on health and mortality [5–7]. In Scotland, all
health service provision is free at the point of access and
there are no financial barriers to care; prescribed medi-
cines are also free. Access to primary care services re-
mains challenging due to stigma, discrimination and
bureaucratic barriers [8, 9]. Unmet health needs are
common [10, 11]. Mental illness, pain and addictions
may be poorly managed [12] with evidence suggesting
under prescribing and low rates of prescription adher-
ence [13, 14] Patterns of emergency healthcare utilisa-
tion differ between people experiencing homelessness
and those who are housed: ED visits, hospitalisations
and readmissions are higher [15, 16]. Reasons also differ,
with people who are homeless experiencing more emer-
gency healthcare contacts for drug, alcohol and mental
health related problems [15, 16].
Availability and uptake of preventative healthcare is
lower [9, 16, 17] and presentations to Family (General)
Practitioners tend to be reactive [18]. Almost one third
of homeless deaths are preventable by timely and effect-
ive use of health services [6] yet there is a lack of
community based effective and cost effective complex
interventions by healthcare professionals, proven to in-
crease anticipatory care and reducing unscheduled care
[19]. In Glasgow, Scotland, a novel, low threshold
Pharmacist led Homeless Outreach Engagement and
Nonmedical Independent prescribing (Rx) (PHOENIx)
service is offered to people experiencing homelessness,
by NHS (National Health Service) employee Pharmacist
independent prescribers working with Simon Commu-
nity Scotland (SCS) Outreach workers (third sector
homelessness charity expert in housing assessment, ben-
efits, advocacy and social prescribing) in city centre
venues [20–23]. Aiming to assess and address housing,
health, benefits and social activities, the views of people
experiencing homelessness, and stakeholders (e.g.
General Practitioners, Addictions workers, community
pharmacists, Hostel and Day Centre workers), of the
PHOENIx intervention are favourable [24]. In line with
the development of complex interventions, [25] the aim
of this study was to examine the feasibility of recruit-
ment, retention, the extent of intervention delivery, and
collection of outcome data [26] prior to embarking on a
pilot randomised controlled trial.
Methods
Design
Feasibility and pilot studies are essential precursors to
full scale trials of complex health service / public health
interventions. Feasibility studies precede pilot studies.
Feasibility studies look at specific aspects of the design,
and pilot studies aim to test whether the entire proce-
dures of the full study work together [25, 26].
Patient inclusion
Participants were adult inpatients (≥ 18 years) in a Glas-
gow city centre hospital, at the point of discharge into
the community, who were experiencing homelessness,
and either had no registered GP or were registered with
Glasgow’s Homelessness Health Service. In general,
Scottish hospitals, unlike those in England, [27] have no
specialist ‘step down’ intermediate care service to help
reduce readmissions.
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We aimed to recruit the same number of intervention
and usual care group patients. As part of routine service
provision, the hospital based Acute Homeless Liaison
Team (AHLT) obtained patient consent for referral and
follow up by the PHOENIx team, then referred patients
(by NHS email), to the PHOENIx team. AHLT engage
with patients in hospital to try to construct a plan for
their discharge back into the community. AHLT sup-
plied mobile phones or top up vouchers to patients to
facilitate contact. On receiving a referral from AHLT,
but before contacting the patient, the NHS Pharmacist
accessed the patient’s shared clinical and prescribing re-
cords to collect relevant baseline information. The
PHOENIx team then phoned the patient (if a number
was available) or visited or phoned their place of resi-
dence or visited their begging pitch or one of Glasgow
city centre’s low threshold homeless day shelters, to ar-
range and conduct the first face to face consultation.
PHOENIx team
All four PHOENIx staff, in addition to their expert pro-
fessional skills and experience, were recruited based on
their contextual knowledge, street sense, an attitude of
mutual respect and empathy for patients, and resilience.
The team had an ideology of care including social in-
clusion, and unconditional support [28]. Consultations
with patients involved a Pharmacist and a SCS worker.
Pharmacists were NHS employees, and SCS employed
outreach workers held honorary NHS contracts. The
pharmacists had at least 2 years’ experience as Inde-
pendent Prescribers, and were familiar with assessing
and managing the complex needs of people experien-
cing homelessness. Pharmacist independent prescribers
have undergone additional training in therapeutics and
learning in practice, then passed an exam and have
additional registration with the General Pharmaceutical
Society to legally prescribe any medicine within their
sphere of competency. An independent prescriber can
assess, diagnose and prescribe without the need to in-
volve another healthcare professional. The scope of
practice depends on the training received and the even-
tual role. Pharmacists working in a hospital intensive
care unit may be expected to independently prescribe
any parenteral medicines; whereas a pharmacist work-
ing in an out-patient rheumatology clinic would be
expected to independently prescribe a range of anti-
rheumatic medicines. Independent prescribing pharma-
cists working in homeless health are expected to be
adept at prescribing a wide range of medicines, given
the number of morbidities experienced by people who
are homeless [13, 18]. They access the additional input
of the general practitioners in homelessness health or
other specialists when required [13, 18].
SCS outreach staff had at least 2 years’ experience
caring for people experiencing homelessness, part of a
larger SCS outreach team in Glasgow City Centre. They
were trained in housing and benefits assessment and had
a detailed knowledge of rough sleeping sites and night
shelters in Glasgow city centre. One day per week of
pharmacist time was allocated to the service and 3 days
of SCS outreach worker time.
Intervention
As described previously, and as shown in Fig. 1, the
pharmacist and SCS worker consulted with the patient
to work through a comprehensive health check during
which they assessed, and where possible, began or con-
tinued treatment for: physical or mental health problems
and addictions (Table 1) [20, 22]. Housing, benefits and
social care needs were also assessed. In the case of treat-
ment for opioid dependency, patients were referred to
the relevant specialist service e.g. for same day initiation
of methadone. Prescribing of all other medicines was
undertaken by the pharmacist, after checking relevant
clinical records for evidence of previous recent supply,
or after establishing a new diagnoses needing treatment
e.g. wound infection. The PHOENIx team and the pa-
tient agreed the frequency of return consultations. A low
caseload (less than 10 patient visits per working day) en-
abled sufficient time to offer repeated outreach visits,
and minimised the risk of staff being overwhelmed in
the process of supporting patients with multiple com-
plex needs including, in most cases, traumatic experi-
ences that the patient may or may not have shared
previously. The team accepted the patient’s priorities
and progressed at the patient’s pace, for example, if the
patient had untreated hepatitis C infection but wanted
to prioritise dental treatment, the team worked with the
patient and dental support worker, to engage the patient
in dental treatment. The pharmacist remotely accessed
and updated relevant NHS clinical patient data systems
during each consultation, and the SCS worker remotely
accessed and updated relevant social care and third sec-
tor care records.
Usual care
Patients who could not be reached despite at least four
phone calls over 4 days and who could not be traced in
Glasgow City centre streets/homeless accommodation
were deemed uncontactable and assigned to the UC
group. Patients in both groups continued to receive
health and social care and medicines as usual from all
existing providers.
UC for patients who are homeless and discharged
from hospital comprised a referral letter sent electronic-
ally to the patient’s registered GP, summarising the ad-
mission diagnoses and treatments given, with a note of
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the patient’s 7 day discharge prescription (if any) and
planned follow up (if any). The patient received a copy
of this, and was expected to attend or contact their GP
practice for a continuation prescription of these medi-
cines if indicated, and for follow up care. If the patient
had an addiction, the addiction team in the hospital
communicated with the addiction team in primary care,
to ensure continuation of supply of treatments for
addictions e.g. methadone or buprenorphine for opiate
addiction.
Glasgow’s Homelessness Health Service registers
people who are homeless, if the patient attends the prac-
tice. It provides comprehensive primary care (GP and
Nursing services, plus referral to other services who visit
the Homelessness Health Service at fixed times every
week e.g. podiatry, dieticians, oral health, Blood Borne
Virus Nurse specialists). The homelessness addiction
and mental health services are co-located. People who
are homeless are free to retain their registration with a
mainstream GP practice rather than register with the
Homelessness Health Service.
Glasgow has approximately 38 discrete temporary
locations for multiple occupancy temporary accommo-
dation for people who are homeless, providing approxi-
mately 800 beds. For those people in Glasgow who are
homeless and accommodated by Glasgow City Council
services, accommodation ranges from those with 24 h
staff supervision (for patients detoxing from alcohol/
drugs or both) to Bed and Breakfasts with no supervision
or cooking facilities.
Outcomes
Outcome measures were: rates of recruitment; retention,
uptake of the intervention (proportion of patients
Fig. 1 Flow of patients during the study
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receiving the intervention as planned) and the extent of
collection of baseline and outcome data (number and
type of Emergency Department (ED) visits and hospitali-
sations differentiated by physical, mental ill health or ad-
dictions; proportion of out-patient appointment
attendances). The period of observation for outcome
data was the period from 19th March 2018 (the date of
referral into the service (UC group patients) or date of
first contact (intervention group patients) until the cen-
sor date of 24th Aug 2019 or death if sooner.
Data
Data were assessed using electronic surveillance of med-
ical records for all participants. An NHS employee re-
searcher with read only access to clinical systems
transcribed relevant data onto an EXCEL spreadsheet,
stored on a password protected NHS desktop computer,
ready for summary and analysis. All transcribed data
were checked for accuracy and completeness. Pre-
specified baseline data included demographics, accom-
modation type, registration with GP/other services and
acute services attendance in the past year. Follow up
data included changes implemented during consulta-
tions, and clinical outcomes (number and type of acute
care contacts). Baseline data were obtained by looking
up each patient’s clinical records, using their unique per-
sonal health number (Community Health Index (CHI)
number). Actions resulting from intervention delivery
were recorded by pharmacists and SCS workers as part
of routine service delivery. Outcome data were collected
as follows, from clinical records: when patients are dis-
charged from ED or hospital, a summary letter including
reason for attendance appears on the patient’s shared
primary and secondary care clinical record (Clinical Por-
tal). The primary reason for ED attendance was taken
from the patient’s emergency attendance letter (‘present-
ing complaint’ or ‘diagnosis’ or ‘significant operations or
procedures’) and reasons for hospitalisation taken from
the immediate discharge letter (‘primary diagnosis’ or
‘secondary diagnosis’). These were categorised as either:
physical health; mental health; or addictions by the NHS
employee researcher. Where there was no reason given,
the researcher accessed a separate, shared clinical record
(Trakcare) for the same episode of care, to collect the
ICD 10 code assigned to each episode of care (‘current
diagnosis’ or ‘presenting complaint’). In cases where
there was no coded diagnosis or ‘no injury or abnormal-
ity detected’ or no entry in the relevant TRAK section,
the ‘clinical comments’ section of the immediate dis-
charge letter or ‘reason for attendance’ was used.
Statistical analyses
Continuous data were summarised using mean (SD) or
median (IQR). For categorical data, percentages were
calculated. All analyses were conducted by an NHS re-
searcher and repeated by another member of the re-
search team, using MINITAB version 18 [29].
Results
Patient characteristics at baseline
Twenty four patients (approximately 5 % of the eligible
population during the study period) were offered and
agreed to referral to the PHOENIx service, between 19th
March 2018 and 6th April 2019. After referral, 12
Table 1 PHOENIx intervention and usual carea
Timeline Activity
19th March 2018 -
24th August 2019
Intervention: patient access to GP, hospital and other services as normal.
Plus PHOENIx consultations assessing:
˗ Quality of Life;
˗ Accommodation;
˗ Debt;
˗ Social activity/interests;
˗ Cardiovascular disease;
˗ Respiratory disease
˗ Nutrition screen;
˗ Footcare;
˗ Drug and alcohol use;
˗ Prescribed medicines and review;
˗ Mental health;
˗ Blood Borne Viruses;
˗ Sexual health;
˗ Wounds;
˗ Fractures;
˗ Teeth;
˗ Eyesight;
˗ Skin.
Following assessment, the patient prioritises their own issues, and the PHOENIx
team treat, prescribe and refer where appropriate.
A plan for the next visit is agreed.
Usual care: patient access to GP, hospital
and other services as normal.
aat least four unsuccessful phone calls over four days, and cannot be traced in Glasgow City centre streets/homeless accommodation
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patients could not be reached and therefore formed a
UC group. Table 2 shows baseline demographics.
Nine (75%) patients in the intervention group and five
(46%) in the UC group were discharged into temporary
homeless accommodation; three in the intervention
group and two in the UC group were rough sleeping
after discharge. Eleven (92%) patients in the intervention
group and six (50%) in the UC group were registered
with the specialist Homeless Health Service Addiction
Team, meaning the patients were known to have prob-
lem drug or alcohol use and recently received treatment.
The proportions of patients registered with specialist
homeless vs. mainstream GP practices were comparable
between groups. Three patients in the intervention
group and two in the UC group were known to the City
Ambition Network (CAN) and therefore had a named
key worker. CAN is a partnership involving Glasgow city
Council, homeless charities and criminal justice, estab-
lished to identify and support patients who repeatedly or
persistently became homeless, or were in frequent con-
tact with criminal justice services.
Baseline health-care utilisation
Table 3 describes acute services healthcare utilisation, in
the 12 month period prior to referral.
Hospital visits (ED, hospitalisation and out-patient ap-
pointments) were comparable between groups in the 12
month period before each patient was referred to
PHOENIx. Physical health problems and addictions were
the most common reasons for hospitalisations. Most pa-
tients (8 (67%) in both groups had scheduled out-patient
appointments, with a median of 4 in both groups in the
year preceding the intervention; the majority of appoint-
ments were missed. Seven (58%) patients in the inter-
vention group and nine (75%) patients in the usual care
group had at least one irregular (left hospital against
medical advice, without their care plan completed) dis-
charge with a median of 0.1 and 0.2 irregular discharges
respectively.
Figure 1 describes patient flow through the service. Of
the 12 patients who could not be reached, the team
learned (from the SCS Street team) the location of six
patients. The remaining six patients could not be traced.
All 12 patients who were reached received the interven-
tion as planned. Following the initial engagement, the
team made 174 subsequent attempts to engage the pa-
tient (speak on phone or meet face to face) (median 12.5
(IQR 5.5–15.8) per patient) in the intervention group
leading to 114 consultations (median 7.5 (3.0–14.2) per
patient. No patients who were contactable, declined the
offer of any PHOENIx team consultations.
The first patient was referred and seen on the same
day (19th March 2018); the 24th patient was referred on
6th April 2019, receiving their first health assessment on
24th April 2019. Due to limited availability of the NHS
researcher, the censor date was 24th August 2019.
Table 4 summarises process outcomes.
Locations for health checks included the patients’ tem-
porary accommodation or low threshold venues e.g. city
centre day centres or evening soup kitchens. The team
routinely offered patients clothing, food and drink.
Clinics were in the afternoons or evenings. Following
clinical assessment, pharmacists made new diagnoses:
six patients received new physical health problem diag-
noses e.g. deep vein thrombosis. Four had new diagnoses
of mental health problems e.g. depression, and one pa-
tient had a new diagnoses of opiate addiction. Subse-
quently, pharmacists prescribed a median of two (IQR
0.3–3.8) new prescriptions per patient. All but one pa-
tient received prescriptions for pre-existing repeat medi-
cines. Immediate treatment e.g. for wound care, was
received by seven patients. Most patients were offered
support for benefits: a median 1.5 interventions (IQR 1–
5) per patient were focussed on benefits, housing or ad-
vocacy. Complex needs and a high level of multidiscip-
linary team working is evidenced by the range and
number of onward referrals. Because of the difficulties
experienced by patients navigating complex health and
social care systems, and missing appointments, in most
cases, the team organised transport for patients to go to,
and return from these appointments, to reduce the
burden.
Health services utilisation outcomes
Outcomes (Table 5) until censor date were collated for
each patient using routine NHS data sources. In the
Table 2 Patient characteristics at baselinea
Intervention
n = 12
Usual
care n = 12
Demographics
Age (years) 42 (36–47) 39 (33.5–47.5)
Sex (male) 10 (83) 10 (83)
Ethnicity (white Scottish) 12 (100) 12 (100)
Accommodation
Temporary e.g. hostel 9 (75) 5 (46)
Street 3 (25) 2 (17)
Sofa surfing 0 (0) 2 (17)
Unknown 0 (0) 3 (25)
General Practitioner
Homeless Health Service 10 (83) 8 (67)
No recent GP 2 (17) 4 (33)
Registration with other services
Homeless Addiction Team 11 (92) 6 (50)
City Ambition Network 3 (25) 2 (17)
aN (%) or median (IQR).
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intervention group, there were no deaths during follow
up (median 5 (range 1–12) months. Two patients in the
UC group died of drug/alcohol overdose; reducing the
duration of follow up to a median 4 (range 2–7) months.
Table 5 shows there was a signal of a reduction in the
number of ED attendances per patient in the interven-
tion group at follow up: Intervention group 0.7
attendances/patient year (IQR 0.5–0.9) vs. UC 1.6 atten-
dances/patient year (0.8–4.2). The Intervention group
ED attendance rate at follow up also represents a reduc-
tion compared to baseline (pre-intervention): median
number of ED attendances /patient year in the Interven-
tion group at baseline: 1.0 (0.6–1.5) (Table 3) vs 0.7
(0.5–0.9) (Table 5) at follow up. ED attendances/patient
year doubled during the study period for patients in the
UC group (from 0.8 (0.7–1.6) ED attendances /patient
year at baseline (Table 3) to 1.6 (0.8–4.2) attendances/
patient year at follow up (Table 5)).
Table 3 Baseline health care utilisationa
Intervention n = 12 Usual Care n = 12
ED attendance2
All cause
Patients 12 (100) 12 (100)
Attendances/patient year 1.0 (0.6–1.5) 0.8 (0.7–1.6)
Physical health
Patients 11 (92) 10 (83)
Attendances/patient year 0.6 (0.5–0.9) 0.4 (0.1–0.8)
Mental health
Patients 5 (42) 4 (33)
Attendances/patient year 0 (0.0–0.2) 0 (0.0–0.1)
Addictions
Patients 8 (67) 10 (83)
Attendances/patient year 0.2 (0.0–0.5) 0.5 (0.1–0.8)
Unspecified
Patients 0 2 (17)
Attendances/patient year 0.0 (0.0–0.0) 0.0 (0.0–0.0)
Hospitalisation
All cause
Patients 12 (100) 11 (92)
Hospitalisations/patient year 0.6 (0.4–0.8) 0.5 (0.3–0.7)
Physical health
Patients 11 (92) 11 (92)
Hospitalisations/patient year 0 (0.0–0.2) 0 (0.0–0.1)
Mental health
Patients 4 (33) 0
Hospitalisations/patient year 0.0 (0.0–1) 0
Addictions
Patients 8 (67) 8 (67)
Hospitalisations/patient year 0.1 (0.0–0.2) 0.0 (0.0–0.0)
Scheduled outpatient appointments
Patients 8 (67) 8 (67)
Appointments/patient year 4.0 (4.3) 4.3 (6.3)
Attended
Patients 6 (50) 6 (50)
Attendances/patient year 1.0 (1.3) 1.8 (3.4)
a N (%) or median (IQR)
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However, there was no difference in the number of
patients experiencing ED attendances with 11 patients
in each group having at least one ED attendance.
This suggests patients in the usual care group had
more repeat ED attendances than those in the inter-
vention group. Nine patients from the usual care
group were hospitalised compared with 11 in the
intervention group; the increase may have been driven
by more attendances due to mental or physical health
causes, identified by the PHOENIx team during the
course of the intervention. Outpatient appointments
increased in the intervention group relative to usual
care, and patients in the intervention group had
increased attendance, which was encouraged and facil-
itated by the PHOENIx team during and after the
intervention.
Discussion
The aim of the study was to examine the feasibility of re-
cruitment, retention, the extent of intervention delivery
and collection of outcome data, prior to a pilot rando-
mised controlled trial. Twenty four people experiencing
homelessness were offered, and 24 agreed to participate
in the study. Half were subsequently engaged and re-
ceived serial health checks leading to prescribing, and
onward referral. Six of the 12 who were un-contactable,
could be traced but their circumstances contra-indicated
a visit from the PHOENIx team or researchers suggest-
ing overall recruitment in a subsequent RCT with the
need for face to face baseline assessment, would be in
the region of 50%, which is similar to one previous study
[30]. The sample size of any planned pilot study would
therefore require to be doubled. Engagement and
Table 4 Intervention group: contacts and interventions
Patients n (%) Per patient (n = 12) a
Contact attempts 12 (100) 12.5 (5.5–15.8)
Successful contact attempts 12 (100) 7.5 (3–14.3)
Health check including medication review 12 (100) 2.5 (2–3)
Additional clinical assessment
Physical health 6 (50) 0.5 (0–1)
Mental health 4 (30) 0.0 (0–1)
Addictions 4 (30) 0.0 (0–1)
New diagnosis
Physical health 6 (50) 0.5 (0–1.8)
Mental health 4 (30) 0.0 (0–1)
Addiction 1 (8.3) 0.0 (0–1)
Prescriptions issued
New 9 (75) 2.0 (0.3–3.8)
Repeat 11 (91.7) 2.0 (1.3–7.0)
Immediate treatment 7 (58.3) 0.0 (0–1)
Supplies b 9 (75) 3 (0.3–3.8)
Direct referral (appointment +/− transport)
GP 10 (83.3) 1 (1–2)
Mental health 4 (30) 0 (0–1)
Addictions 6 (50) 0.5 (0–1.8)
Complex needs 7 (58.3) 1 (0–1)
Other e.g. ED 7 (58.3) 1 (0–4.5)
Social visit
PHOENIx 9 (75) 1.5 (0.3–4.5)
PHOENIx plus other intervention workers 3 (25) 0 (0–0.8)
Appointment reminder 6 (50) 0.5 (0–2)
Benefits / Housing / Advocacy 10 (83.3) 1.5 (1–5)
a Median (IQR) per patient; bMedicines, food, clothes, Gregory Pecks, books etc.
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retention with the intervention was excellent (all partici-
pants in the intervention arm engaged with the team
throughout the duration of the study). There was no loss
to follow up in terms of accessing participants’ hospital
clinical records, providing a low cost approach to col-
lecting follow up acute health service utilisation data in
a subsequent pilot study.
Fewer patients had missed appointments in the inter-
vention group with fewer missed appointments per pa-
tient, possibly due to the PHOENIx team arranging out
patient appointments and supporting travel arrange-
ments. The team also supported patients to attend their
GP, although primary health care utilisation data were
not sought during this study. The team encouraged
patients to go directly to ED where this was deemed ne-
cessary, particularly out of hours when GP surgeries
were closed. This may account for the slightly higher
number of patients with hospitalisations in the interven-
tion group, particularly for mental health problems.
Patients interviewed in a recent qualitative study sug-
gested the PHOENIx team may directly improve health
[24]. By design, the current study lacks the power to de-
termine if the intervention does objectively improve
health, however our findings (recruitment, retention, up-
take of the intervention, extent of data collection) war-
rant further examination in a randomised controlled
pilot study, with parallel health economic and qualitative
process evaluation to assess implementation potential.
Strengths and limitations
Recruitment and attrition difficulties in trials involving
people experiencing homelessness is described
previously [31–33]. Our recruitment method (AHLT ap-
proaching patients in hospital) achieved 100% recruit-
ment of targeted patients, but 50% subsequently
unavailable for baseline assessment suggests the need for
baseline assessment at the point of recruitment in
hospital, or participant incentives e.g. vouchers, or add-
itional approaches e.g. peer recruiters.
Participants’ characteristics were similar to those de-
scribed in previous studies [13, 15, 18, 34]; increasing
the chances of generalisability in different settings and
healthcare systems. Findings can be compared to the
characteristics of patients experiencing homelessness in
Glasgow (Lowrie F et al) [22] and Glasgow/Edinburgh
(Zeitler et al) [13]. A comparison of the study sample
Table 2 (patient characteristics) with the samples de-
scribed by Lowrie [22] and Zeitler [13] show similarity
in terms of age and sex, but our current sample had a
higher prevalence of drug use (92% compared with 62%
[22], and 73% [13]), hostel dwelling (60% vs 40% [22])
and rough sleeping (21% vs 13%) [22]. These differences
are possibly explained by previous studies sampling ex-
clusively from patients registered with the Homeless
Health services in Glasgow and Edinburgh, whereas our
inclusion criteria were homelessness and discharged
from hospital, 75% of whom had and 25% had no regis-
tered GP. Lack of any type of accommodation and not
having a registered GP together suggests a lower level of
priority attached to, or difficulty associated with GP
registration, by patients in our sample.
The complex PHOENIx intervention included compo-
nents seen as important from the perspective of a person
experiencing homelessness e.g. the immediacy of re-
sponse [24, 35]. It was delivered as planned, with pa-
tients receiving a median of seven consultations each
following 12 attempts by the PHOENIx team, and no re-
fusals, suggesting acceptability in our sample.
Table 5 Health services utilisation outcomes a
Intervention
n = 12
Usual care
n = 12
Emergency Department (ED) (attendances (all cause)
Patients 11 (92) 11 (92)
Attendances /patient year 0.7 (0.5–0.9) 1.6 (0.8–4.2)
Physical health
Patients 10 (83) 9 (75)
Attendances/ patient year 0.4 (0.2–0.5) 0.4 (0.1–1.4)
Mental health
Patients 5 (42) 6 (50)
Attendances /patient year 0.0 (0.0–0.2) 0.1 (0.0–0.3)
Addictions
Patients 6 (50) 7 (58)
Attendances /patient year 0.1 (0.0–0.4) 0.3 (0.0–1.0)
Hospitalisations (all causes)
Patients 11 (92) 9 (75)
Hospitalisations /patient year 0.5 (0.4–0.7) 0.6 (0.1–1.3)
Physical health
Patients 9 (75) 7 (58)
Attendances /patient year 0.2 (0.9–0.4) 0.3 (0.0–0.6)
Mental health
Patients 5 (42) 1 (8)
Attendances/patient year 0.1 (0.1–0.1) 0.0 (0.0–0.0)
Addictions
Patients 5 (42) 5 (42)
Attendances/patient year 0.0 (0.0–0.4) 0.0 (0.0–0.3)
Scheduled outpatient appointments
Patients 8 (67) 5 (42)
Appointments/patient year 0.7 (0.18–1.1) 0.0 (0.0–0.5)
Attended
Patients 8 (67) 3 (25)
Attended/patient year 0.2 (0.0–0.8) 0.0 (0.0–0.3)
a N(%) or median (IQR)
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The PHOENIx response to the patient’s health check
was tailored, and the patient’s shared primary and sec-
ondary care clinical record was updated at each consult-
ation. A wide range of problems were identified and
resolved during the consultation. Detailed actions taken
as a result of patient consultations, have been described
previously [20–22]. Many of the changes to prescribing
are evidence based e.g. initiation of an antidepressant for
a major depressive episode, and would be expected to
reduce the risk of depression causing or contributing to
ED attendance. In this feasibility study, by design,
limited inferences can be made about the link between
prescribing, adherence and health service utilisation out-
comes. In a subsequent pilot or definitive study, with a
larger sample, if there is a difference in pre-specified
outcomes between groups, we would be able to consider
how, by prescribing and on occasion, going to a phar-
macy and having the medicines dispensed then taken
back to patients, adherence would likely improve. In
turn, if the prescription was a direct treatment for a spe-
cified condition e.g. an infection, or essential to prevent
a medical emergency e.g. insulin for a type 1 diabetic, it
is likely that subsequent ED visits would be averted in a
short time period. The team delivering the intervention
were adept at gaining patients’ trust which is known to
be important for improving health outcomes [35] and
enlisting the support of a wide range of individuals from
diverse organisations, to prioritise and co-ordinate care
for people with complex needs. The intervention team
may have helped to reduce patients’ treatment burden
[36]. Treatment burden refers to the demands made of
patients by healthcare systems. It includes the work pa-
tients have to do to gain an understanding of their
health problems, the engagement work they do to access
services and treatments (including prescriptions), the
work of attending appointments, undergoing investiga-
tions and taking medication, as well as self monitoring
work they may have to undertake. An example of the
treatment burden experienced by people experiencing
homelessness, who have a median of 6 or 7 long term
conditions, is adhering to complex treatment regimens,
or organising already challenging life circumstances to
order and re-order their medicines, or attend different,
un-co-ordinated services for their mental, physical and
addictions long term conditions [36]. Partnership work-
ing with GPs is a pre-requisite to co-ordination of pri-
mary care: clinical governance for the PHOENIx team
rested with the Homelessness Health Service GP service.
Independent Prescriber Pharmacists and Nurses, and
SCS street outreach workers are available to provide this
intervention beyond the life of the feasibility study, as
part of routine service, underscoring opportunities for
rollout into routine primary care should the intervention
prove beneficial, and cost effective. Outcome measures
in this study were relevant, built on previous work, inex-
pensive to collect, objectively assessed, and reproducible.
Surrogate end points could be assessed in subsequent
trials, however unlike patients recruited in previous trials
of patients recruited because of a single condition, [37–
39] people experiencing homelessness have multiple
complex health and social care needs meaning outcomes
are more diverse. Subsequent pilot work on the PHOE-
NIx intervention could evaluate patient reported out-
comes, or effectiveness using health state utilities (for a
future cost utility analysis) e.g. through the use of EQ-
5D-5L to generate Quality Adjusted Life Years which
could then be used alongside cost data to give an indica-
tive picture of cost effectiveness. Two previous UK based
studies of patients experiencing homelessness have in-
cluded economic analyses [40, 41].
It is possible that patients allocated to the usual care
group had greater levels of unmet health needs than
those who could be reached. Because of the additional
difficulty associated with engaging with these patients,
they are likely to have had fewer contacts with services
e.g. health and social care, addictions, more chaotic life-
styles and perhaps lower prioritisation of health needs
and worse health. Randomisation in any subsequent
controlled pilot study is needed to reduce selection bias
however those who are hard to reach may remain so
even within the context of a RCT. In some settings,
where the majority of people experiencing homelessness
are migrants and low paid workers, and in healthcare
systems that are not free at the point of use, our findings
may not be generalizable.
Through our pragmatic trial we aim to demonstrate
improvements in the quality and reductions in the cost
of care. Quality could be measured by patients receiving
more appropriate care through being able to access first
contact, co-ordinated, continuous care by the PHOENIx
team who act as a bridge back into GPs and other spe-
cialists in homelessness health [24]. In order to decrease
ED visits through an intervention, we need a sufficient
number of ED visits for any reduction to be visible. To
maximise the chances of an intervention showing a dif-
ference between intervention and control groups in a
subsequent trial, targeting patients with higher rates of
baseline ED presentations may be more appropriate, or
those with higher ED presentations due to physical
health problems, given the tendency for the team to as-
sess, diagnose and treat physical health problems.
A small number of patients were recruited, but recom-
mendations for sample sizes in feasibility studies are
sparse, because the aim is to examine recruitment, re-
tention, intervention fidelity and outcomes [25, 26, 42,
43]. A recent systematic review of RCTs, non RCTs and
controlled before-after studies of interventions to im-
prove care of people who are homeless, identified only
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one feasibility study, with nine participants (six interven-
tion; three control) [19]. More definitive RCTs are
needed, including assessment of a wider range of out-
comes e.g. quality of life measures, primary care health
utilisation, and duration of hospitalisation.
Comparison with existing literature
In accordance with the recommended stages of complex
intervention testing, [25] the PHOENIx intervention was
developed and optimised previously [20–22, 24]. The
pairing of third sector worker and pharmacist independ-
ent prescriber on outreach, as far as we are aware, is a
novel approach to improving engagement and uptake of
health and social care interventions in people who are
homeless [19]. The only other pharmacist led interven-
tion study in this area did not include assessment of
wider health needs, prescribing or referral, or offer serial
encounters [44].
Systematic and other reviews have described health in-
terventions to improve health in people who are home-
less. However there are no known effective and cost
effective ‘off the shelf’ interventions involving healthcare
professionals [19, 45, 46].
Our target population are people who pay the ultimate
price of extreme inequity: they experience severe and
multiple disadvantage across their lives and often die
sooner because they are worse off. Our findings suggest
a pilot study of the intervention would be justified, and
thereafter, a definitive randomised controlled trial. If the
definitive study shows reduction in emergency health
service utilisation, or length of hospitalisation, or fewer
deaths in the intervention group with causality attribut-
able to the PHOENIx intervention, then we will have
created an intervention to address one aspect of inequity
in health for people experiencing homelessness.
The lack of published feasibility and pilot studies pre-
ceding definitive RCTs, suggests previous investigators
may not have worked through the phases of developing
their complex interventions, introducing the possibility
of weaknesses in the reporting and conduct of their de-
finitive trials [46, 47]. In terms of generalisability of the
study population, observed ED visit rates were lower
than those reported in studies from Canada [30, 48] and
North America [49]. Multiple factors interact to influ-
ence healthcare utilisation in people who are homeless,
however the lower rates observed in our study are sur-
prising given the high rates of mental health and sub-
stance misuse in our target group [13, 18], which are
associated with higher rates of ED use. Differences in ac-
cess and payment in different health care systems may
also explain differential ED rates [50].
Interventions involving tailoring primary care to
people who are homeless have been tried previously to
decrease ED use [51] or complex interventions which
include respite and social care/housing support [52] al-
though not in the context of adequately powered RCTs.
The PHOENIx intervention is tailored to individuals
over time, combining assessment of health, with housing
and opportunities to involve patients in social activities,
because housing is an integral component of disease
management [53, 54] and having a structure and pur-
pose to daily life is rated as important for patients to re-
main healthy [53]. The diverse range of outcomes
described in this feasibility study suggest the PHOENIx
intervention assessed and addressed factors that take
precedence over health care in addition to the predispos-
ing needs that drive health seeking behaviour [54]. The
social prescribing component of the PHOENIx interven-
tion offered patients an opportunity to move into a place
of safety by day and night. We offered patients oppor-
tunities to occupy their time with productive, meaning-
ful activities. These activities took patients away from
the city centre streets where they ordinarily would spend
their time and where drug use and violence was likely.
Assessment and intervention to address homelessness
led to some patients obtaining accommodation, or better
accommodation, giving them a place of relative safety by
night, as compared with rough sleeping for example. We
suspect most people would regard these components of
the intervention as important priorities, in a hierarchy of
needs, which underpin good health and may be a pre-
requisite to seeking healthcare, at least healthcare that
the patient may view as non urgent.
Conclusions
Trialling a collaborative, pharmacist independent pre-
scriber and third sector homelessness charity worker
outreach intervention is feasible in the context of a non
randomised trial, suggesting merit in progressing to a
randomised controlled pilot study with embedded
process and economic evaluation.
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